These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8624081)
41. Alzheimer's disease and control brain contain soluble derivatives of the amyloid protein precursor that end within the beta amyloid protein region. Pasternack JM; Palmert MR; Usiak M; Wang R; Zurcher-Neely H; Gonzalez-De Whitt PA; Fairbanks MB; Cheung T; Blades D; Heinrikson RL Biochemistry; 1992 Nov; 31(44):10936-40. PubMed ID: 1420205 [TBL] [Abstract][Full Text] [Related]
42. Regulation of Alzheimer beta-amyloid precursor trafficking and metabolism. Gandy S; Petanceska S Biochim Biophys Acta; 2000 Jul; 1502(1):44-52. PubMed ID: 10899430 [TBL] [Abstract][Full Text] [Related]
43. Plasmalogen synthesis is regulated via alkyl-dihydroxyacetonephosphate-synthase by amyloid precursor protein processing and is affected in Alzheimer's disease. Grimm MO; Kuchenbecker J; Rothhaar TL; Grösgen S; Hundsdörfer B; Burg VK; Friess P; Müller U; Grimm HS; Riemenschneider M; Hartmann T J Neurochem; 2011 Mar; 116(5):916-25. PubMed ID: 21214572 [TBL] [Abstract][Full Text] [Related]
44. The beta A4 amyloid protein precursor in human circulation. Bush AI; Beyreuther K; Masters CL Ann N Y Acad Sci; 1993 Sep; 695():175-82. PubMed ID: 8239279 [TBL] [Abstract][Full Text] [Related]
45. SNX27 and SORLA Interact to Reduce Amyloidogenic Subcellular Distribution and Processing of Amyloid Precursor Protein. Huang TY; Zhao Y; Li X; Wang X; Tseng IC; Thompson R; Tu S; Willnow TE; Zhang YW; Xu H J Neurosci; 2016 Jul; 36(30):7996-8011. PubMed ID: 27466343 [TBL] [Abstract][Full Text] [Related]
46. Regulation of cytokine secretion and amyloid precursor protein processing by proinflammatory amyloid beta (A beta). Gitter BD; Boggs LN; May PC; Czilli DL; Carlson CD Ann N Y Acad Sci; 2000; 917():154-64. PubMed ID: 11268339 [TBL] [Abstract][Full Text] [Related]
47. Inhibition of death-associated protein kinase 1 attenuates the phosphorylation and amyloidogenic processing of amyloid precursor protein. Kim BM; You MH; Chen CH; Suh J; Tanzi RE; Ho Lee T Hum Mol Genet; 2016 Jun; 25(12):2498-2513. PubMed ID: 27094130 [TBL] [Abstract][Full Text] [Related]
48. Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Lee RK; Wurtman RJ; Cox AJ; Nitsch RM Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8083-7. PubMed ID: 7644542 [TBL] [Abstract][Full Text] [Related]
49. JNK regulates APP cleavage and degradation in a model of Alzheimer's disease. Colombo A; Bastone A; Ploia C; Sclip A; Salmona M; Forloni G; Borsello T Neurobiol Dis; 2009 Mar; 33(3):518-25. PubMed ID: 19166938 [TBL] [Abstract][Full Text] [Related]
50. Folic acid deficiency enhances abeta accumulation in APP/PS1 mice brain and decreases amyloid-associated miRNAs expression. Liu H; Tian T; Qin S; Li W; Zhang X; Wang X; Gao Y; Huang G J Nutr Biochem; 2015 Dec; 26(12):1502-8. PubMed ID: 26345540 [TBL] [Abstract][Full Text] [Related]
51. Amino-truncated amyloid beta-peptide (Abeta5-40/42) produced from caspase-cleaved amyloid precursor protein is deposited in Alzheimer's disease brain. Takeda K; Araki W; Akiyama H; Tabira T FASEB J; 2004 Nov; 18(14):1755-7. PubMed ID: 15364896 [TBL] [Abstract][Full Text] [Related]
52. Cryptotanshinone, a compound from Salvia miltiorrhiza modulates amyloid precursor protein metabolism and attenuates beta-amyloid deposition through upregulating alpha-secretase in vivo and in vitro. Mei Z; Zhang F; Tao L; Zheng W; Cao Y; Wang Z; Tang S; Le K; Chen S; Pi R; Liu P Neurosci Lett; 2009 Mar; 452(2):90-5. PubMed ID: 19154776 [TBL] [Abstract][Full Text] [Related]
53. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex. Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051 [TBL] [Abstract][Full Text] [Related]
54. New insights into serotonin 5-HT4 receptors : a novel therapeutic target for Alzheimer's disease? Maillet M; Robert SJ; Lezoualc'h F Curr Alzheimer Res; 2004 May; 1(2):79-85. PubMed ID: 15975071 [TBL] [Abstract][Full Text] [Related]
55. Normal processing of the Alzheimer's disease amyloid beta protein precursor generates potentially amyloidogenic carboxyl-terminal derivatives. Estus S; Golde TE; Younkin SG Ann N Y Acad Sci; 1992 Dec; 674():138-48. PubMed ID: 1288359 [No Abstract] [Full Text] [Related]
56. APP Receptor? To Be or Not To Be. Deyts C; Thinakaran G; Parent AT Trends Pharmacol Sci; 2016 May; 37(5):390-411. PubMed ID: 26837733 [TBL] [Abstract][Full Text] [Related]
58. Candidate anti-A beta fluorene compounds selected from analogs of amyloid imaging agents. Hong HS; Maezawa I; Budamagunta M; Rana S; Shi A; Vassar R; Liu R; Lam KS; Cheng RH; Hua DH; Voss JC; Jin LW Neurobiol Aging; 2010 Oct; 31(10):1690-9. PubMed ID: 19022536 [TBL] [Abstract][Full Text] [Related]
59. Muscarinic agonists in Alzheimer's disease. Growdon JH Life Sci; 1997; 60(13-14):993-8. PubMed ID: 9121366 [TBL] [Abstract][Full Text] [Related]
60. Abnormalities in brain glucose utilization and its impact on cellular and molecular mechanisms in sporadic dementia of Alzheimer type. Hoyer S Ann N Y Acad Sci; 1993 Sep; 695():77-80. PubMed ID: 8239317 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]